Which country is Dasatinib (Dasatinib) produced by?

Dasatinib is manufactured by Bristol-Myers Squibb. Bristol-Myers Squibb is a global pharmaceutical company headquartered in New York, USA. The company focuses on the research and development, production and sales of various drugs covering multiple therapeutic areas, including cardiovascular, immunology, oncology, metabolic diseases, etc. Dasatinib (Startase)As an important product of the company, it is widely used to treat patients with chronic myelogenous leukemia (CML) and some acute lymphoblastic leukemia (ALL).

Bristol-Myers Squibb has advanced research and development and manufacturing facilities and is committed to providing high-quality, innovative pharmaceutical products to meet the medical needs of patients around the world. Dasatinib (Stacer) as a targeted therapy drug, plays an important role in the treatment of CML and ALL and has been widely used clinically and recognized.

As an international pharmaceutical company, Bristol-Myers Squibb has extensive market coverage and sales network around the world, and its products including dasatinib (Startax) and a variety of pharmaceutical products are sold around the world. This makes it easier for patients to obtain dasatinib (Startase) and receive timely treatment.

Dasatinib (Dasatinib) is now on the market in China and has been included in the medical insurance system. Patients can purchase it directly in China, with the price ranging from RMB 4,000 to RMB 5,000. For specific drug pricing and medical insurance reimbursement ratios, patients are asked to go to the pharmacy of their local hospital for detailed consultation. In addition, the price of foreign generic drugs of Dasatinib (Startase) is relatively more affordable, usually only a few hundred yuan, which has a significant price advantage compared with domestic drugs. It is worth noting that the ingredients of original drugs marketed in China and foreign generic drugs are highly consistent. Therefore, when patients choose drugs, they can make reasonable choices based on their actual situation and economic conditions.